Fresenius Medical Care Ag (FMS) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Fresenius Medical Care Ag  (NYSE: FMS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Fresenius Medical Care Ag's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Fresenius Medical Care Ag's ROI in the fourth quarter of 2025?
Fresenius Medical Care Ag achieved a return on average invested assets (ROI) of 4.86 % in its fourth quarter of 2025, which is below Fresenius Medical Care Ag's average return on investment, which stands at 6.49%.

ROI has improved compared to 3.57% in the third quarter of 2025, due to net income growth.

Within the Healthcare sector 192 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 1865.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM -10.7 % -8.12 % -6.12 % -3.13 % 0.14 %
Y / Y Net Income Change TTM 68.02 % 6.46 % 39.06 % 115.65 % 190.1 %
Investment (TTM) in Millions 27,728 27,728 27,728 27,728 30,582
Return On Investment (TTM) 4.86 % 3.57 % 3.17 % 2.9 % 2.58 %
FMS's Overall Ranking # 1865 # 0 # # #
Seq. Investment Change TTM -2.51 % -2.45 % -3.01 % -3.19 % 0.3 %
Seq. Net Income Change TTM 32.66 % 10.02 % 5.72 % 8.89 % -15.94 %
Net Income (TTM) in Millions 1,347 1,015 923 873 802

FMS Company Profile >> Back to FMS Roi Comparisons >> See Annual FMS Return On Investment



Return On Investment FMS's Ranking
Within: No.
Industry # 23
Sector # 193
Overall # 1865

Return On Investment Statistics
High Average Low
13.66 %
6.49 %
2.71 %
0   (Dec 31 2024)







Financial Statements
Fresenius Medical Care Ag's IV. Quarter Investments $ 27,728 Millions FMS's Balance sheet
Fresenius Medical Care Ag's IV. Quarter Income $ 456 Millions Quarterly FMS's Income Statement
FMS's Income by Division See FMS's Income by Division


FMS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 27,728 30,582 30,206 32,013 30,298
Y / Y Investment Growth -9.33 % 1.25 % -5.64 % 5.66 % 13.28 %
Net Income in Millions 1,334 830 820 1,002 1,365
Y / Y Net Income Growth 60.79 % 1.15 % -18.1 % -26.64 % -15.1 %
Annual Return On Investment 4.81 % 2.71 % 2.72 % 3.13 % 4.51 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 4.81 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FMS's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FMS's Competitors
Subscribers only: Roi for Fresenius Medical Care Ag's Suppliers
Subscribers only: Return On Investment for FMS's Customers

Other Ratios
FMS's Roa FMS's Inventory Turnover Ratio FMS's Growth Rates FMS's Dividend Statistics
FMS's Profitability Ratios FMS's Asset Turnover Ratio FMS's Dividend Growth
FMS's Roe FMS's Valuation Ratios FMS's Financial Strength Ratios FMS's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI
Alkermes Plc   12.98 %
Regeneron Pharmaceuticals Inc   12.63 %
Novartis Ag  12.62 %
Universal Health Services Inc   12.38 %
Lantheus Holdings Inc   12.33 %
Prestige Consumer Healthcare Inc   12.12 %
Msa Safety Inc  12.06 %
Amgen Inc   11.95 %
Encompass Health Corporation  11.94 %
Solventum Corporation  11.89 %
Ufp Technologies Inc   11.88 %
Alpha Pro Tech Ltd   11.70 %
Globus Medical Inc   11.70 %
Nrc Health  11.33 %
Nephros Inc   11.27 %
3m Company  11.03 %
Pacific Health Care Organization Inc  10.98 %
Nature s Sunshine Products inc   10.95 %
Progyny Inc   10.84 %
Escalon Medical Corp   10.78 %
Qiagen N v   10.69 %
Cryoport inc   10.68 %
Siga Technologies Inc  10.57 %
Ligand Pharmaceuticals Incorporated  10.56 %
Healthcare Services Group Inc   10.55 %
Genmab A  10.37 %
Bristol myers Squibb Company  10.36 %
Brainsway Ltd   10.35 %
Kiniksa Pharmaceuticals International Plc  10.32 %
Penumbra Inc  10.30 %

Date modified: 2026-09-08T17:43:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.